Knight Therapeutics Inc. (OTCMKTS:KHTRF – Get Free Report)’s share price was up 0.8% on Thursday . The stock traded as high as $5.36 and last traded at $5.36. Approximately 7,062 shares were traded during trading, an increase of 73% from the average daily volume of 4,089 shares. The stock had previously closed at $5.32.
Knight Therapeutics Price Performance
The firm’s 50-day moving average is $4.57 and its 200-day moving average is $4.40.
About Knight Therapeutics
Knight Therapeutics Inc (OTCMKTS:KHTRF) is a specialty pharmaceutical company headquartered in Montreal, Canada, focused on acquiring, in-licensing and commercializing innovative branded products for the Canadian and Latin American markets. The company secures exclusive marketing and distribution rights to medicines across multiple therapeutic areas, including ophthalmology, pain management, hematology and women’s health. Its portfolio features both prescription pharmaceuticals and specialty products that address unmet patient needs through targeted treatments.
Operating primarily in Canada, Mexico and select Latin American countries, Knight has established strategic alliances with global pharmaceutical firms to introduce novel therapies at various stages of development.
Read More
Receive News & Ratings for Knight Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
